The global endocrine system drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Endocrine drugs are agents directed to a malfunctioning endocrine path. Several agents are secreted in or target the nervous system and are thus more prone to cause neurologic adverse events (AEs). The major factor for the growth of the global endocrine system drugs market is the increasing prevalence of the endocrine disease.
Furthermore, these diseases include endocrine glands associated disorders such as Addison’s disease, gigantism, goitre, Cushing’s syndrome, polycystic ovary syndrome (PCOS), diabetes, hypertension, hyperlipidemia, acromegaly, thyroiditis, and osteomalacia. Additionally, the market is also growing due to the increasing number of the adolescent populace as they are more prone to these diseases due to hormonal imbalances.
To Request a Sample of our Report on Endocrine System Drugs Market: https://www.omrglobal.com/request-sample/endocrine-system-drugs-market
Some major players in the market include Novo Nordisk A/S, Eli Lilly and Company, and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2020, Novartis received the approval of Istrusia (osilodrostat) by the US FDA. It is oral tablets used for the treatment of adult Cushing’s disease patients who cannot undergo pituitary gland surgery or who have had the surgery, however, still have the disease.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Novo Nordisk A/S, Eli Lilly and Company, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Endocrine System Drugs Market is Available @ https://www.omrglobal.com/industry-reports/endocrine-system-drugs-market
Global Endocrine System Drugs Market Report by Segment
By Type
- Diabetes Drug
- Human Growth Hormones
- Thyroid Hormone Disorder Drugs
- Others
By Application
- Hospitals
- Clinics
- Medical Center
- Other
Global Endocrine System Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
